It is vital to begin asking questions about your company’s DSCSA readiness and compliance, as well as that of your strategic partners, writes Rob Besse.
Rob Besse
Advertisement
Rob Besse is Vice President, Archbow Consulting.
Articles by Rob Besse
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
Why Integrated GMP Operating Models Are Reshaping Outsourced Manufacturing
3
The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma
4
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
5